Vincristine Treatment Protects Against Podocyte Damage in Focal Segmental GlomerulosclerosisWilliam J. Mason, Ruth J. Pepper, Scott R Henderson et al.|Kidney International Reports|2025Cited by 3
Vincristine Treatment Produces a Milieu Which Reverses Podocyte Damage in Focal Segmental GlomerulosclerosisWilliam J. Mason, Ruth J. Pepper, Jennifer C. Chandler et al.|Journal of the American Society of Nephrology|2022Cited by 0
Vincristine treatment reverses podocyte damage in focal segmental glomerulosclerosisWilliam J. Mason, Ruth J. Pepper, David A. Long et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0